LOGO ZF Pill - orange oval, 10mm
Generic Name: paricalcitol
Pill with imprint LOGO ZF is Orange, Oval and has been identified as Zemplar 2 mcg. It is supplied by Abbott Laboratories.
Zemplar is used in the treatment of Secondary Hyperparathyroidism and belongs to the drug class vitamins. Risk cannot be ruled out during pregnancy. Zemplar 2 mcg is not a controlled substance under the Controlled Substances Act (CSA).
Images for LOGO ZF




Zemplar
- Generic Name
- paricalcitol
- Imprint
- LOGO ZF
- Strength
- 2 mcg
- Color
- Orange
- Size
- 10.00 mm
- Shape
- Oval
- Availability
- Prescription only
- Drug Class
- Vitamins
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Abbott Laboratories
- Inactive Ingredients
-
gelatin,
glycerin,
titanium dioxide,
water,
ferric oxide red,
ferric oxide yellow,
alcohol,
butylated hydroxytoluene,
medium-chain triglycerides
Note: Inactive ingredients may vary.
Labelers / Repackagers
NDC Code | Labeler / Repackager |
---|---|
00074-4314 (Discontinued) | Abbott Laboratories |
68382-0267 (Discontinued) | Zydus Pharmaceuticals USA Inc. |
See also:
Sensipar
Sensipar reduces elevated levels of parathyroid hormone in people with chronic renal disease who ...
Botox
Botox is used for cosmetic purposes and to treat overactive bladder symptoms, urinary incontinence ...
Doxercalciferol
Doxercalciferol is used for secondary hyperparathyroidism
Cinacalcet
Cinacalcet is used for hypercalcemia of malignancy, primary hyperparathyroidism, secondary ...
More about Zemplar (paricalcitol)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Generic availability
- Drug class: vitamins
- En español
Patient resources
- Zemplar drug information
- Zemplar (Paricalcitol Intravenous) (Advanced Reading)
- Zemplar (Paricalcitol Oral) (Advanced Reading)
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.